Days after Elon Musk released some “Twitter Files,” President Joe Biden’s administration launched an investigation of a Musk-owned company.
The Department of Agriculture’s inspector general opened an investigation of Neuralink on a prosecutor’s request, according to a Reuters report. The legal action comes despite Neuralink employees acknowledging no monkey business has occurred in the treatment of test animals.
The Daily Wire further reported:
The neurotechnology company is developing “ultra high bandwidth brain-machine interfaces to connect humans and computers,” according to its website.
The report said that the investigation centers around potential violations of the Animal Welfare Act, which “regulates the treatment of animals in research, teaching, testing, exhibition, transport, and by dealers,” according to the agency.
The report admits that “Neuralink treats animals quite well compared to other research facilities,” according to interviews with employees. Executives at the company have talked of building a “Monkey Disneyland” at one testing facility while wanting the animals to live in a “monkey Taj Mahal” at another location.
A small number of employees at the company have reportedly claimed that Musk’s insistence on pushing for faster times in getting products to the point where they can be tested on humans has led to mistakes in the tests that have been conducted on various animals, including monkeys and pigs.
The employees allege that the mistakes have led to more animals having to be killed because of botched surgeries and because the experiments have to be conducted again. The animals are often killed at the end of the experiments because post mortem analysis is often needed to determine the effectiveness of the experiment.
Some of the mistakes that have reportedly plagued the experiments are simple in nature, like implanting the wrong device or implanting a device in on the wrong vertebra of animals.
The news comes after Musk said last week that he expects a the company’s wireless brain chips to enter human clinical trials within the next six months. The goal of the implants is to help disabled people be able to move and communicate.
“We want to be extremely careful and certain that it will work well before putting a device into a human,” Musk said. “The progress at first, particularly as it applies to humans, will seem perhaps agonizingly slow, but we are doing all of the things to bring it to scale in parallel. So, in theory, progress should be exponential.”